Cheray, Mathilde <br/><br/>
Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness.  [electronic resource] 

 -  Epigenomics  Jun 2014 
 - 267-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1750-192X 
<br/><br/><label>Standard No.: </label>10.2217/epi.14.18  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Proliferation--drug effects<br/>DNA (Cytosine-5-)-Methyltransferase 1<br/>DNA (Cytosine-5-)-Methyltransferases--antagonists & inhibitors<br/>Dacarbazine--analogs & derivatives<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Epigenesis, Genetic<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Glioma--drug therapy<br/>Mice<br/>Neoplasm Transplantation<br/>Peptides--pharmacology<br/>Temozolomide<br/>Trans-Activators--antagonists & inhibitors